These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25186130)

  • 21. Visualizing the atherosclerotic plaque: a chemical perspective.
    Teresa Albelda M; Garcia-España E; Frias JC
    Chem Soc Rev; 2014 Apr; 43(8):2858-76. PubMed ID: 24526041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-resolution MRI of carotid plaque with a neurovascular coil and contrast-enhanced MR angiography: one-stop shopping for the comprehensive assessment of carotid atherosclerosis.
    Tartari S; Rizzati R; Righi R; Deledda A; Capello K; Soverini R; Benea G
    AJR Am J Roentgenol; 2011 May; 196(5):1164-71. PubMed ID: 21512087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
    Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
    Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraperitoneal injection improves the uptake of nanoparticle-labeled high-density lipoprotein to atherosclerotic plaques compared with intravenous injection: a multimodal imaging study in ApoE knockout mice.
    Jung C; Kaul MG; Bruns OT; Dučić T; Freund B; Heine M; Reimer R; Meents A; Salmen SC; Weller H; Nielsen P; Adam G; Heeren J; Ittrich H
    Circ Cardiovasc Imaging; 2014 Mar; 7(2):303-11. PubMed ID: 24357264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histological validation of iron-oxide and gadolinium based MRI contrast agents in experimental atherosclerosis: the do's and don't's.
    den Adel B; Bovens SM; te Boekhorst B; Strijkers GJ; Poelmann RE; van der Weerd L; Pasterkamp G
    Atherosclerosis; 2012 Dec; 225(2):274-80. PubMed ID: 22882907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new class of Gd-based DO3A-ethylamine-derived targeted contrast agents for MR and optical imaging.
    Mishra A; Pfeuffer J; Mishra R; Engelmann J; Mishra AK; Ugurbil K; Logothetis NK
    Bioconjug Chem; 2006; 17(3):773-80. PubMed ID: 16704217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gadospin F-enhanced magnetic resonance imaging for diagnosis and monitoring of atherosclerosis: validation with transmission electron microscopy and x-ray fluorescence imaging in the apolipoprotein e-deficient mouse.
    Jung C; Dučić T; Reimer R; Koziolek E; Kording F; Heine M; Adam G; Ittrich H; Kaul MG
    Mol Imaging; 2014; 13():. PubMed ID: 25342533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compensatory UTE/T2W Imaging of Inflammatory Vascular Wall in Hyperlipidemic Rabbits.
    Kim B; Yang J; Lee YH; Kim MH; Heo D; Lee E; Suh JS; Haam S; Huh YM
    PLoS One; 2015; 10(5):e0124572. PubMed ID: 25978437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid-rich atherosclerotic plaques detected by gadofluorine-enhanced in vivo magnetic resonance imaging.
    Sirol M; Itskovich VV; Mani V; Aguinaldo JG; Fallon JT; Misselwitz B; Weinmann HJ; Fuster V; Toussaint JF; Fayad ZA
    Circulation; 2004 Jun; 109(23):2890-6. PubMed ID: 15184290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of gadolinium-based MRI contrast agents in biological and environmental samples: a review.
    Telgmann L; Sperling M; Karst U
    Anal Chim Acta; 2013 Feb; 764():1-16. PubMed ID: 23374209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Switchable MRI contrast agents based on morphological changes of pH-responsive polymers.
    Okada S; Mizukami S; Kikuchi K
    Bioorg Med Chem; 2012 Jan; 20(2):769-74. PubMed ID: 22206870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly relaxing gadolinium based MRI contrast agents responsive to Mg2+ sensing.
    Abada S; Lecointre A; Elhabiri M; Esteban-Gómez D; Platas-Iglesias C; Tallec G; Mazzanti M; Charbonnière LJ
    Chem Commun (Camb); 2012 Apr; 48(34):4085-7. PubMed ID: 22430859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of intravascular contrast agents for MRI using gadolinium chelates.
    Kittigowittana K; Yang CT; Cheah WC; Chuang KH; Tuang CY; Chang YT; Golay X; Bates RW
    ChemMedChem; 2011 May; 6(5):781-7. PubMed ID: 21433294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The complex fate in plasma of gadolinium incorporated into high-density lipoproteins used for magnetic imaging of atherosclerotic plaques.
    Barazza A; Blachford C; Even-Or O; Joaquin VA; Briley-Saebo KC; Chen W; Jiang XC; Mulder WJ; Cormode DP; Fayad ZA; Fisher EA
    Bioconjug Chem; 2013 Jun; 24(6):1039-48. PubMed ID: 23617731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic resonance imaging features of vulnerable plaques in an atherosclerotic rabbit model.
    Zhao XC; Zhao QM; Ma XH; Zeng CH; Feng TT; Zhao X; Zhang ZQ; Zhang MD; Zhuang XC
    Chin Med J (Engl); 2013; 126(11):2163-7. PubMed ID: 23769577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanistic studies of Gd3+-based MRI contrast agents for Zn2+ detection: towards rational design.
    Bonnet CS; Caillé F; Pallier A; Morfin JF; Petoud S; Suzenet F; Tóth É
    Chemistry; 2014 Aug; 20(35):10959-69. PubMed ID: 25116889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gd(Try-TTDA)(H2O)]2-: a new MRI contrast agent for copper ion sensing.
    Kasala D; Lin TS; Chen CY; Liu GC; Kao CL; Cheng TL; Wang YM
    Dalton Trans; 2011 May; 40(18):5018-25. PubMed ID: 21451883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular biodegradable macromolecular gadolinium(III) complexes for MRI.
    Lu ZR; Parker DL; Goodrich KC; Wang X; Dalle JG; Buswell HR
    Magn Reson Med; 2004 Jan; 51(1):27-34. PubMed ID: 14705042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclodextrin polyrotaxanes as a highly modular platform for the development of imaging agents.
    Fredy JW; Scelle J; Guenet A; Morel E; de Beaumais SA; Ménand M; Marvaud V; Bonnet CS; Tóth E; Sollogoub M; Vives G; Hasenknopf B
    Chemistry; 2014 Aug; 20(35):10915-20. PubMed ID: 25069825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-relaxivity MRI contrast agents prepared from miniemulsion polymerization using gadolinium(III)-based metallosurfactants.
    Gong P; Chen Z; Chen Y; Wang W; Wang X; Hu A
    Chem Commun (Camb); 2011 Apr; 47(14):4240-2. PubMed ID: 21359276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.